Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 23,140 $ 27,615
Short-term investments 0 9,874
Accounts receivable, net 3,211 2,665
Inventory, net 7,911 9,303
Prepaid expenses and other current assets 1,910 1,723
Total current assets 36,172 51,180
Property and equipment, net 1,389 806
Operating lease rights of use 3,564 1,895
Software license inventory 386 450
Licensing rights 1,041 1,028
Other assets 109 131
Total assets 42,661 55,490
Current liabilities:    
Accounts payable 393 272
Accrued compensation 2,947 2,824
Other accrued liabilities 1,053 2,065
Operating lease liabilities, current portion 424 561
Deferred product and service revenue, current portion 2,613 1,066
Total current liabilities 7,430 6,788
Operating lease liabilities, net of current portion 3,568 1,532
Deferred product and service revenue, net of current portion 541 390
2020 senior secured convertible note payable, net 9,949 9,893
Total liabilities 21,488 18,603
Commitments and contingencies (Note 8)
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, $0.01 par value; 25,000,000 shares authorized at December 31, 2023 and 2022; none issued and outstanding at December 31, 2023 and 2022 0 0
Common stock, $0.01 par value; 90,000,000 shares authorized at December 31, 2023 and 200,000,000 shares authorized at December 31, 2022; 24,652,729 and 24,578,983 shares issued and outstanding at December 31, 2023 and 2022, respectively 247 246
Additional paid-in capital 193,382 187,008
Accumulated deficit (172,456) (150,367)
Total stockholders’ equity 21,173 36,887
Total liabilities and stockholders’ equity $ 42,661 $ 55,490
Common stock, authorized (in shares) 90,000,000 200,000,000